Symptomatic loosening of a total knee arthroplasty caused by a tibial chondrosarcoma – a case report
© Sieker et al.; licensee Springer. 2014
Received: 16 November 2013
Accepted: 16 June 2014
Published: 24 June 2014
Premature implant loosening following total knee arthroplasty (TKA) can have several causes. In this article we report on a rare case of a 74 year old male patient suffering tibial component loosening 14 month after primary TKA. The patient did neither have any malignancies nor joint arthroplasty before. Upon clinical examination the range of motion in the diseased knee was painfully restricted to 80° of knee flexion, with the patient increasingly suffering sleeping and resting pain, and also at weight bearing. In standard radiographs, loosening of the TKA due to a large osteolysis at the tibial component was evident. Local computed tomography (CT) of the right knee revealed loosening of the tibial component due to a presumably malign bone tumor. For determination of the final diagnosis a representative biopsy of the tumor was taken by open surgery prior to the tumor resection. Histopathologic evaluation of the biopsy revealed a periprosthetic myxoid chondrosarcoma of the proximal tibia. Pre-operative staging examination included CT scans of lung and abdomen, as well as a bone scintigraphy which revealed no signs of tumor metastasis in the body. Surgical management comprised wide tumor resection and implantation of a hinged tumor knee arthroplasty with replacements of the distal femur and proximal tibia, as well as a patella tendon replacement using a synthetic ligament. Revision surgery was necessary twice due to impaired wound healing and critical soft tissue coverage, and treatment included a gastrocnemius muscle flap with skin mesh graft covering. Unfortunately long-term follow-up examinations could not be obtained, as the patient deceased due to an alveolitis during rehabilitation. In summary, the specifics of this rare case of aseptic TKA loosening, and the unusual circumstances of chondrosarcoma diagnosis and treatment are informative for those providing surgical treatment of similar cases.
Chondrosarcoma is an invasive musculoskeletal neoplasm, which is assumed to originate from malign transformed mesenchymal precursor cells, capable of forming a collagenous matrix (Aigner 2002). According to an analysis from the SEER (Surveillance, Epidemiology and End Results) Database the estimated annual incidence is 1/200000 with a mean age of 55 years (Giuffrida et al. 2009). Most frequently chondrosarcoma is located in the appendicular (44.5%) or axial skeleton (31.1%) (Giuffrida et al. 2009). The usual presentation of bone malignancies includes pain, due to destruction of the bone architecture, swelling and occasionally compression of surrounding structures. When bone malignancy is suspected from clinical presentation and supported by radiographic imaging, referral to a specialized interdisciplinary center for further imaging and biopsy according to the American Joint Committee on Cancer (AJCC) guidelines is recommended (Ofluoglu et al. 2010; Edge et al. 2009).
When specified, the most common histological subtype is the myxoid chondrosarcoma (56%), followed by the mesenchymal (25%), dedifferentiated (10%), juxtacortical (4%), malignant chondroblastoma (4%) and clear cell subtype (2%) (Giuffrida et al. 2009). The survival rates differ between histological subtypes and grading, with a thirty year survival rate of low-grade chondrosarcomas (G1 and G2) being 76%, compared to 50% in high-grade tumors (G3 and G4) (Giuffrida et al. 2009).
The predominant treatment of chondrosarcoma is surgical, with the status of the resection margins (R0, R1 or R2) being related with the rate of local recurrence (Giuffrida et al. 2009; Goda et al. 2011). Though skeletal and non-skeletal chondrosarcomas are described to have a high radiation- and chemotherapy-resistance (Onishi et al. 2011; Moussavi-Harami et al. 2006), clinical trials with successful radiation-treatment (Drilon et al. 2008; Rutz et al. 2008) or case-reports with promising chemotherapy application (Drilon et al. 2008; Dallas et al. 2012; Han et al. 2010) do exist. Here we report the diagnostic and surgical management, as well as the short-term outcome of a 76-year-old patient with tibial chondrosarcoma presenting with symptoms of prosthetic loosening 14 month after primary TKA.
The patient presented himself in our outpatient clinic 14 month after primary TKA which was implanted due to symptomatic knee osteoarthritis (OA) elsewhere. The pre-operative radiographs with anterior-posterior (ap.) and lateral view of the right knee are shown (Figure 1a and b). After an initial symptom-relief, stress-dependent pain reoccurred few months after the surgery. After a phase of stable symptoms, exacerbation occurred approximately 12 months postoperatively, including resting and sleeping pain, which triggered the referral to our outpatient clinic with suspicion of prosthetic loosening.
Staging was then completed and the case was discussed in the local interdisciplinary tumor board. In summary a local disease stage, without infiltration of popliteal structures or metastases was present, and a wide resection of the tumor with inclusion of the knee prosthesis was indicated according to the disease stage. Since limb-preserving resection and reconstruction is technically tedious and carries the risk of incomplete resection and local recurrence, amputation was also discussed with the patient and his family. In consideration of all pros and cons of the respective approaches, the patient wished to undergo wide tumor resection and reconstruction with a distal femur and proximal tibia replacing hinged knee prosthesis. This was then planned using the radiographs and CT-scans (Figure 1c-f), with the projected resections being located 8 cm proximal of the joint line at the femur and 15 cm distally of the joint line at the tibia. For the reconstruction the MML tumor knee system for distal femoral and proximal tibial replacement (Modular endoprosthetic system Munich-Lübeck, Orthodynamics GmbH, Lübeck, Germany) was chosen (Salis-Soglio et al. 2010), with an alloplastic reconstruction of the extensor mechanism (Holzapfel et al. 2011).
Resection of the knee joint with proximal tibia: Resection steps included scar excision, resection of the inner part of the patella with complete patellar-tendon (Figure 2a), resection of the joint capsule under preservation of the muscle-insertions of the pes-anserinus (Figure 2a) and the biceps-femoris tendons. Resection was initially performed as previously planned as soft tissue structures were without signs of tumor infiltration. After en-bloc resection the distal marrow showed suspicious tissue, therefore the intraoperative decision to extent the resection 5 cm distally was made (Figure 2b), which resulted in macro- and microscopically tumor free margins. The femoral resection was performed as planned 8 cm proximal of the joint line to match the planned implant, while no suspect bone or soft tissue changes were observed at the resection margins (Figure 2c). All resected tissues were sent in for histopathological examination. For reconstruction medullary canals were prepared followed by implantaion of trial-components for joint-line resonstruction, resulting in full extension and flexion without instability. Thorough irrigation was performed between steps and prior to cement fixation of the original components in the previously tested sizes. After reposition and connection, the previously detached tendons were reattached using FiberWire ® sutures (Arthrex, Naples, FL, USA), with reconstruction of the patellar tendon being performed using a Trevira synthetic ligament (Telos, Marburg, Germany) (Figure 2d-f), before tension free wound closure was performed. After surgery full weight-bearing with an extension brace and continuous passive motion was allowed.
The described case presented with symptomatic loosening 14 months after TKA. Although reports of implant-related sarcoma formation do exist, in these the minimal observed interval from implantation to sarcoma diagnosis was 2.5 years (Keel et al. 2001). Since our case presented with an extensive tumor size early after TKA and an osteolytic lesion was described in the protocol of the externally performed surgery, we suspect that the chondrosarcoma was present during initial surgery. However, a biopsy, obtained from the osteolytic lesion during primary TKA remained inconclusive. Towards the management of patients with an extensive osteolytic lesion in combination with OA, we recommend the open-incision biopsy prior to TKA and the evaluation in a pathological institute with expertise in musculoskeletal malignancies.
Towards the decision between amputation and prosthetic reconstruction, the local tumor extension, especially in relation to the adjacent nerves and vasculature, is important. In the presented case, the vasculature sparing R0 resection was possible and the limb-preservation using a proximal tibia replacing knee prosthesis was performed according to the patient’s wish. For resection, a surgical approach through the patella bone was chosen, comprising the whole knee capsule, patellar and quadriceps tendon, followed by alloplastic reconstruction. Though technically feasible, this procedure obviously carries the risk of soft tissue loss, predisposing for wound-healing problems above the insertion site of the alloplastic graft. In our case, a primary soft tissue coverage using a gastrocnemius-flap-graft maybe would have enabled for faster wound healing and recovery. Therefore, soft tissue muscle flaps should be readily indicated and performed, when soft tissue coverage of large metal implants appears critical or insufficient.
Regrettably, after further progress towards mobility during his stationary rehabilitation, the patient deceased from an alveolitis. Post mortem examination to investigate the etiology of the lung disease was not performed. Therefore this case report is limited to the diagnostic and operative management, as well as the short-term outcome at discharge from our stationary care.
The comparison of outcomes with alternative surgical procedures (endoprosthetic reconstruction versus amputation) is hardly possible, due to the low incidence and different stages of the disease. To date, no clinical trial comparing outcomes of tumor replacing joint arthroplasty and amputation in joint-involving chondrosarcoma does exist to our knowledge. Therefore decision of surgical management is highly individual, primarily depending on disease stage, grade and patient preferences.
This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing.
- Aigner T: Towards a new understanding and classification of chondrogenic neoplasias of the skeleton – biochemistry and cell biology of chondrosarcoma and its variants. Virchows Arch 2002, 441(3):219-230. doi:10.1007/s00428-002-0641-xView ArticleGoogle Scholar
- Dallas J, Imanirad I, Rajani R, Dagan R, Subbiah S, Gaa R, Dwarica WA, Ivey AM, Zlotecki RA, Malyapa R, Indelicato DJ, Scarborough MT, Reith JD, Gibbs CP, Dang LH: Response to sunitinib in combination with proton beam radiation in a patient with chondrosarcoma: a case report. J Med Case Rep 2012, 6: 41. doi:10.1186/1752-1947-6-41View ArticleGoogle Scholar
- Drilon AD, Popat S, Bhuchar G, D’Adamo DR, Keohan ML, Fisher C, Antonescu CR, Singer S, Brennan MF, Judson I, Maki RG: Extraskeletal myxoid chondrosarcoma: a retrospective review from 2 referral centers emphasizing long-term outcomes with surgery and chemotherapy. Cancer 2008, 113(12):3364-3371. doi:10.1002/cncr.23978View ArticleGoogle Scholar
- Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A: AJCC Cancer Staging Handbook: From the AJCC Cancer Staging Manual. Springer, Heidelberg; 2009.Google Scholar
- Giuffrida AY, Burgueno JE, Koniaris LG, Gutierrez JC, Duncan R, Scully SP: Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database. J Bone Joint Surg Am 2009, 91(5):1063-1072. doi:10.2106/JBJS.H.00416View ArticleGoogle Scholar
- Goda JS, Ferguson PC, O’Sullivan B, Catton CN, Griffin AM, Wunder JS, Bell RS, Kandel RA, Chung PW: High-risk extracranial chondrosarcoma. Cancer 2011, 117(11):2513-2519. doi:10.1002/cncr.25806View ArticleGoogle Scholar
- Han K, Sun Y-J, Shen Z, Zhang JJ, Lin F, Zhao H, Meerani S, Yao Y: Extraskeletal myxoid chondrosarcoma: a case report of complete remission by chemotherapy and review of the literature. BMJ Case Rep 2010 2010. doi:10.1136/bcr.07.2009.2128Google Scholar
- Holzapfel B, Rechl H, Lehner S, Pilge H, Gollwitzer H, Steinhauser E: Alloplastic reconstruction of the extensor mechanism after resection of tibial sarcoma. Sarcoma 2011 2011. doi: 10.1155/2011/545104Google Scholar
- Keel SB, Jaffe KA, Nielsen GP, Rosenberg AE: Orthopaedic implant-related sarcoma: a study of twelve cases. Mod Pathol 2001, 14(10):969-977. doi:10.1038/modpathol.3880420View ArticleGoogle Scholar
- Moussavi-Harami F, Mollano A, Martin JA, Ayoob A, Domann FE, Gitelis S, Buckwalter JA: Intrinsic radiation resistance in human chondrosarcoma cells. Biochem Biophys Res Commun 2006, 346(2):379-385. doi:10.1016/j.bbrc.2006.05.158View ArticleGoogle Scholar
- Ofluoglu O, Boriani S, Gasbarrini A, De Iure F, Donthineni R: Diagnosis and planning in the management of musculoskeletal tumors: surgical perspective. Semin Intervent Radiol 2010, 27(2):185-190. doi:10.1055/s-0030-1253516View ArticleGoogle Scholar
- Onishi AC, Hincker AM, Lee FY: Surmounting chemotherapy and radioresistance in chondrosarcoma: molecular mechanisms and therapeutic targets. Sarcoma 2011, 2011: 1-8. doi:10.1155/2011/381564View ArticleGoogle Scholar
- Rutz HP, Weber DC, Goitein G, Ares C, Bolsi A, Lomax AJ, Pedroni E, Coray A, Hug EB, Timmermann B: Postoperative spot-scanning proton radiation therapy for chordoma and chondrosarcoma in children and adolescents: initial experience at paul scherrer institute. Int J Radiat Oncol Biol Phys 2008, 71(1):220-225. doi:10.1016/j.ijrobp.2007.09.014View ArticleGoogle Scholar
- Salis-Soglio G, Ghanem M, Meinecke I, Ellenrieder M, Klinger HM, Kirchhoff C: The modular endoprothetic system Munich-Luebeck (MML): potential applications and results in lower extremities. Orthopaede 2010, 39(10):960-967. doi: 10.1007/s00132-009-1569-5View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.